|
|
||||||||
Journal of Lipid Research, Vol 37, 1632-1645, Copyright © 1996 by Lipid Research, Inc.
G Feussner, H Scharnagl, C Scherbaum, J Acar, J Dobmeyer, J Lohrmann, H Wieland and W Marz
A new apolipoprotein (apo) E variant, apoE5 (Glu212-->Lys) was
identified in a Turkish family. The variant was due to a point mutation
(CAG-->AAG) at the first nucleotide position of the codon encoding amino
acid residue 212 of the mature apoE. The 23-year-old index patient was
heterozygous for the mutation. Examination of the proband's kindred
revealed six heterozygous and two homozygous mutation carriers. Compared to
non-carriers, carriers of the mutation had slightly higher triglycerides
(1.25 versus 1.11 g/l) and lower HDL cholesterol (0.36 versus 0.41 g/l).
Very low density lipoproteins (VLDL) from an apoE5 (Glu212-->Lys)
homozygote displayed enhanced binding (+17%, P < 0.05), but decreased
uptake (-35%, P < 0.0001) and degradation (-51%, P < 0.0001) in
cultured fibroblasts, compared to E3/3-VLDL. The region of the apoE
molecule surrounding residue 212 contains a heparin binding domain.
Consistently, the enhanced cell surface binding of E5/5-VLDL was observed
in "wild-type" Chinese hamster ovary cells (+19%, P < 0.05), but not in
proteoglycan-deficient cells. The binding of E5/5- VLDL to heparin was
increased (+22%, P < 0.05). As the endocytosis of apoE-containing
particles involves the transfer of proteoglycan-bound ligands to
lipoprotein receptors, the stronger binding of apoE5 (Glu212- ->Lys) to
proteoglycans could reduce the rate at which the mutant is finally
delivered to endocytotic pathways. These data may provide evidence for a
functionally important heparin binding site around amino acid residue 212
of the apoE molecule in vivo.
ARTICLES
Apolipoprotein E5 (Glu212-->Lys): increased binding to cell surface proteoglycans but decreased uptake and lysosomal degradation in cultured fibroblasts
Medizinische Universitatsklinik Heidelberg, Germany.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Dong, M. E. Balestra, Y. M. Newhouse, and K. H. Weisgraber Human apolipoprotein E7: lysine mutations in the carboxy-terminal domain are directly responsible for preferential binding to very low density lipoproteins J. Lipid Res., November 1, 2000; 41(11): 1783 - 1789. [Abstract] [Full Text] |
||||
![]() |
T. Yamamura, L.-M. Dong, and A. Yamamoto Characterization of apolipoprotein E7 (Glu244'Lys, Glu245'Lys), a mutant apolipoprotein E associated with hyperlipidemia and atherosclerosis J. Lipid Res., February 1, 1999; 40(2): 253 - 259. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |